Skip to Main Content

Paper Details

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
British Journal of Clinical Pharmacology
6
2019
B, B-cell malignancies, CLL, Cancer, Lenalidomide, Patients, acute lymphoblastic leukaemia, acute myeloid leukaemia, cancer-types, cancers, chronic lymphocytic leukaemia, creatinine, imide, impaired renal function, lenalidomide, lymphoma, multiple cancers, multiple myeloma, patient, patients, tumour, tumour lysis syndrome
Author NameAffiliation
Stephanie E ReuterSchool of Pharmacy and Medical Sciences, University of South Australia
Craig C HofmeisterComprehensive Cancer Center, The Ohio State University
Craig C HofmeisterThe Ohio State University
  • 1 - 3

Datasets

Release 1.2